Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction

Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction

US Patent 6670366 · Granted Dec 30, 2003

Estimated economic value: $236,324,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic-fused heteroaryl or aryl compounds2025
Bicyclic-fused heteroaryl or aryl compounds2025
Bicyclic-fused heteroaryl or aryl compounds2023
Bicyclic-fused heteroaryl or aryl compounds2023
Bicyclic-fused heteroaryl or aryl compounds2020
Bicyclic-fused heteroaryl or aryl compounds2020
Bicyclic heteroaryl derivatives as CFTR potentiators2020
Pyrrolopyrimidines as CFTR potentiators2019
Bicyclic heteroaryl derivatives as CFTR potentiators2019
Bicyclic-fused heteroaryl or aryl compounds2019
Bicyclic-fused heteroaryl or aryl compounds2019
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators2019